Alpha-adducin polymorphism associated with increased risk of adverse cardiovascular outcomes: results from GENEtic Substudy of the INternational VErapamil SR-trandolapril STudy (INVEST-GENES).

dc.contributor.authors	Gerhard T, Gong Y, Beitelshees AL, Mao X, Lobmeyer MT, Cooper-DeHoff RM, Langaee TY, Schork NJ, Shriver MD, Pepine CJ, Johnson JA; INVEST Investigators.
dc.date.accessioned	2020-02-27T08:30:41Z
dc.date.available	2020-02-27T08:30:41Z
dc.date.issued	2008
dc.identifier.citation	Gerhard T, Gong Y, Beitelshees AL, Mao X, Lobmeyer MT, Cooper-DeHoff RM, Langaee TY, Schork NJ, Shriver MD, Pepine CJ, Johnson JA; INVEST Investigators. (2008). Alpha-adducin polymorphism associated with increased risk of adverse cardiovascular outcomes: results from GENEtic Substudy of the INternational VErapamil SR-trandolapril STudy (INVEST-GENES).. AMERICAN HEART JOURNAL, 156, 404-397
dc.identifier.issn	0002-8703
dc.identifier.uri	https://doi.org/10.1016/j.ahj.2008.03.007
dc.identifier.uri	https://hdl.handle.net/20.500.12619/66230
dc.title	Alpha-adducin polymorphism associated with increased risk of adverse cardiovascular outcomes: results from GENEtic Substudy of the INternational VErapamil SR-trandolapril STudy (INVEST-GENES).
dc.identifier.volume	156
dc.identifier.startpage	397
dc.identifier.endpage	404
dc.contributor.department	Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü
dc.contributor.saüauthor	Akdemir, Ramazan
dc.relation.journal	AMERICAN HEART JOURNAL
dc.identifier.wos	SAU
dc.identifier.doi	10.1016/j.ahj.2008.03.007
dc.contributor.author	Akdemir, Ramazan